Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Cross Talk between MarR-Like Transcription Factors Coordinates the Regulation of Motility in Uropathogenic Escherichia coli.

Luterbach CL, Mobley HLT.

Infect Immun. 2018 Nov 20;86(12). pii: e00338-18. doi: 10.1128/IAI.00338-18. Print 2018 Dec.

2.

PapX, a P fimbrial operon-encoded inhibitor of motility in uropathogenic Escherichia coli.

Simms AN, Mobley HL.

Infect Immun. 2008 Nov;76(11):4833-41. doi: 10.1128/IAI.00630-08. Epub 2008 Aug 18.

4.

Identification and Characterization of a Phase-Variable Element That Regulates the Autotransporter UpaE in Uropathogenic Escherichia coli.

Battaglioli EJ, Goh KGK, Atruktsang TS, Schwartz K, Schembri MA, Welch RA.

MBio. 2018 Aug 7;9(4). pii: e01360-18. doi: 10.1128/mBio.01360-18.

5.

Altered Regulation of the Diguanylate Cyclase YaiC Reduces Production of Type 1 Fimbriae in a Pst Mutant of Uropathogenic Escherichia coli CFT073.

Crépin S, Porcheron G, Houle S, Harel J, Dozois CM.

J Bacteriol. 2017 Nov 14;199(24). pii: e00168-17. doi: 10.1128/JB.00168-17. Print 2017 Dec 15.

6.

Multiple genes repress motility in uropathogenic Escherichia coli constitutively expressing type 1 fimbriae.

Simms AN, Mobley HL.

J Bacteriol. 2008 May;190(10):3747-56. doi: 10.1128/JB.01870-07. Epub 2008 Mar 21.

7.

Fimbrial profiles predict virulence of uropathogenic Escherichia coli strains: contribution of ygi and yad fimbriae.

Spurbeck RR, Stapleton AE, Johnson JR, Walk ST, Hooton TM, Mobley HL.

Infect Immun. 2011 Dec;79(12):4753-63. doi: 10.1128/IAI.05621-11. Epub 2011 Sep 12.

8.

The multifunctional protein YdiV represses P fimbria-mediated adherence in uropathogenic Escherichia coli.

Spurbeck RR, Alteri CJ, Himpsl SD, Mobley HL.

J Bacteriol. 2013 Jul;195(14):3156-64. doi: 10.1128/JB.02254-12. Epub 2013 May 10.

9.

TosR-Mediated Regulation of Adhesins and Biofilm Formation in Uropathogenic Escherichia coli.

Luterbach CL, Forsyth VS, Engstrom MD, Mobley HLT.

mSphere. 2018 May 16;3(3). pii: e00222-18. doi: 10.1128/mSphere.00222-18. eCollection 2018 May-Jun.

10.

Involvement of mismatch repair in the reciprocal control of motility and adherence of uropathogenic Escherichia coli.

Cooper LA, Simmons LA, Mobley HL.

Infect Immun. 2012 Jun;80(6):1969-79. doi: 10.1128/IAI.00043-12. Epub 2012 Apr 2.

11.
12.

Molecular Characterization of the Vacuolating Autotransporter Toxin in Uropathogenic Escherichia coli.

Nichols KB, Totsika M, Moriel DG, Lo AW, Yang J, Wurpel DJ, Rossiter AE, Strugnell RA, Henderson IR, Ulett GC, Beatson SA, Schembri MA.

J Bacteriol. 2016 Apr 28;198(10):1487-98. doi: 10.1128/JB.00791-15. Print 2016 May 15.

13.
14.

Repression of bacterial motility by a novel fimbrial gene product.

Li X, Rasko DA, Lockatell CV, Johnson DE, Mobley HL.

EMBO J. 2001 Sep 3;20(17):4854-62.

15.

Decreased expression of type 1 fimbriae by a pst mutant of uropathogenic Escherichia coli reduces urinary tract infection.

Crépin S, Houle S, Charbonneau MÈ, Mourez M, Harel J, Dozois CM.

Infect Immun. 2012 Aug;80(8):2802-15. doi: 10.1128/IAI.00162-12. Epub 2012 Jun 4.

16.

Signature-tagged mutagenesis and co-infection studies demonstrate the importance of P fimbriae in a murine model of urinary tract infection.

Buckles EL, Luterbach CL, Wang X, Lockatell CV, Johnson DE, Mobley HL, Donnenberg MS.

Pathog Dis. 2015 Jun;73(4). pii: ftv014. doi: 10.1093/femspd/ftv014. Epub 2015 Feb 11.

17.

F9 fimbriae of uropathogenic Escherichia coli are expressed at low temperature and recognise Galβ1-3GlcNAc-containing glycans.

Wurpel DJ, Totsika M, Allsopp LP, Hartley-Tassell LE, Day CJ, Peters KM, Sarkar S, Ulett GC, Yang J, Tiralongo J, Strugnell RA, Jennings MP, Schembri MA.

PLoS One. 2014 Mar 26;9(3):e93177. doi: 10.1371/journal.pone.0093177. eCollection 2014.

18.

Genetic analysis of the role of yfiR in the ability of Escherichia coli CFT073 to control cellular cyclic dimeric GMP levels and to persist in the urinary tract.

Raterman EL, Shapiro DD, Stevens DJ, Schwartz KJ, Welch RA.

Infect Immun. 2013 Sep;81(9):3089-98. doi: 10.1128/IAI.01396-12. Epub 2013 Jun 17.

19.

FNR regulates expression of important virulence factors contributing to pathogenicity of uropathogenic Escherichia coli.

Barbieri NL, Nicholson B, Hussein A, Cai W, Wannemuehler YM, Dell'Anna G, Logue CM, Horn F, Nolan LK, Li G.

Infect Immun. 2014 Dec;82(12):5086-98. doi: 10.1128/IAI.02315-14. Epub 2014 Sep 22.

20.

The UbiI (VisC) Aerobic Ubiquinone Synthase Is Required for Expression of Type 1 Pili, Biofilm Formation, and Pathogenesis in Uropathogenic Escherichia coli.

Floyd KA, Mitchell CA, Eberly AR, Colling SJ, Zhang EW, DePas W, Chapman MR, Conover M, Rogers BR, Hultgren SJ, Hadjifrangiskou M.

J Bacteriol. 2016 Sep 9;198(19):2662-72. doi: 10.1128/JB.00030-16. Print 2016 Oct 1.

Supplemental Content

Support Center